Verdict Email The issues you care about
Medical marvels
-
19 Sep
Brexit and the pharmaceutical industry: guidelines for drug precursors in case of a no-deal
The UK Government has added to its list of industry-focused technical notices laying out its preparations for a possible no-deal Brexit.
-
6 Sep
NHS to fund Europe’s first CAR-T childhood cancer treatment
National Health Service (NHS) England has announced it has come to a deal with Novartis to fund the use of its chimeric antigen receptor T-cell (CAR-T) immunotherapy Kymriah (tisagenlecleucel) for children and young adults under 25 years old with refractory acute lymphoblastic leukaemia (ALL).
-
6 Sep
How close are 3D printed organs to reality?
The financial year of 2017/18 saw the highest number of organs ever donated in the UK.
-
3 Sep
Autonomous drone ambulance wins development funding
A drone ambulance that is capable of operating autonomously while carrying a single injured passenger has been awarded $20,000 to fund its further development.
-
29 Aug
Brexit and the pharmaceutical industry: What happens if there’s no deal?
Concerns about the possibility of a no-deal Brexit in March 2019, when the UK begins its transitional period to leave the EU, have been expressed repeatedly by the pharmaceutical industry.
-
23 Aug
Comparing the US’s ten most expensive drugs with prices in the UK
In recent months, one of US President Donald Trump’s focuses has been to reduce the price of medication in the US, all the way from the most expensive drugs to the cheapest.
-
21 Aug
Six tech giants sign health data interoperability pledge
Google, Amazon, and IBM joined forces with Microsoft, Salesforce, and Oracle to pledge to speed up the progress of health data standards and interoperability.
-
20 Aug
Body GPS provides pinpoint locations for better radiotherapy in cancer treatment
“The ability to continuously sense inside the human body has largely been a distant dream,” said Romit Roy Choudhury, professor of electrical engineering and computer science at the University of Illinois.
-
17 Aug
Five medical device startups to watch
As the demand for new technologies in the medical field continues to grow, so too does the number of ambitious startups looking to fill gaps in the market and provide new solutions to persistent health issues.
-
23 Jul
How two companies are using AI to treat orphan diseases
There is no denying that artificial intelligence (AI) is becoming increasingly prevalent in almost every industry, including healthcare, with applications ranging from robot-assisted surgery to symptom-checking apps already on the market.
-
20 Jul
NHS technology promised £487m boost
The new health secretary Matt Hancock has pledged a major funding package of £487m to transform technology in the NHS during a visit to West Suffolk Hospital.
-
16 Jul
Gene editing roadblock emerges as CRISPR/Cas9 genome damage found
The emerging field of gene editing has hit a significant roadblock as scientists have discovered CRISPR/Cas9, one of the newest and most promising tools for genome editing, can cause far more genetic damage than had previously been realised.
-
16 Jul
FDA prioritises 3D printed drugs
The US Food and Drug Administration (FDA) has outlined the need for advanced manufacturing techniques, such as 3D printed drugs, in the pharmaceutical industry.
-
15 Jul
Could VR therapy transform mental health treatment?
Standing on the edge of a balcony, rescuing a cat from a tree, or performing tasks on the tenth storey of a building.
-
13 Jul
Trump “likely” to pressure UK to change pharmaceutical regulations
US President Donald Trump is “likely” to pressure the UK to change its pharmaceutical regulations as part of post-Brexit trade negotiations, according to an op-ed published in leading medical journal The Lancet.
-
9 Jul
Researchers find a way to control the brain using soundwaves
Researchers believe they have found a way to turn the neural circuits in the brain on and off without using surgery.
-
6 Jul
NHS technology: what does the future hold for healthcare?
Yesterday the UK’s National Health Service celebrated its 70th birthday.
-
6 Jul
Smart bandage monitors wounds and treats them automatically
Engineers from Tufts University have developed a prototype smart bandage that can actively monitor chronic wounds and automatically deliver drug treatments to improve the chances of healing.
-
4 Jul
Synthetic e-skin gives robot hand a human touch
Scientists at the University of Glasgow are developing a synthetic e-skin that can mimic the sense of touch on a robotic hand.
-
3 Jul
British Sugar cannabis meets the world’s medical marijuana needs — but what about the UK?
Last week, the US Food and Drug Administration (FDA) approved Epidiolex for the treatment of seizures associated with two rare and severe forms of epilepsy.
-
13 Jun
Blockchain in pharma: opportunities in the pharmaceutical supply chain
Blockchain is the digital ledger technology that is sweeping through a number of industries on a wave of hype.
-
11 Jun
NHS told to embrace full automation, bedside robots to free up £12.5bn in worker time
The UK’s National Health Service (NHS) has been urged to embrace full automation, including bedside robots and AI diagnoses, to free up frontline staff time worth up to £12.5bn a year – almost 10% of its annual running cost.
-
31 May
Immunotherapy could revolutionise cancer treatment and pharma giants are scrambling to be a part of it
Surgery, radiation therapy and chemotherapy have long been the go-to for cancer treatment.
-
30 May
Can machine learning predict the onset of autism?
The early and accurate diagnosis of autism spectrum disorder (ASD) in children is crucial.
-
21 May
Organ donations in the US are soaring amid the worsening opioid crisis
In the US, organs are in such high demand that 20 people die every day waiting for a transplant.
-
10 May
How the Takeda-Shire deal will change drug development
Japan’s Takeda Pharmaceutical this week agreed to buy Ireland’s Shire for $65 billion.
-
8 May
Takeda’s Shire bid: £46bn bid from Japanese company approved by Shire board
Japan’s Takeda has agreed to buy Dublin-based Shire Pharmaceuticals for £46 billion ($64.42 billion), in what is the sector’s biggest deal since 2000.
-
9 Apr
Novartis share price: Swiss pharma giant buys AveXis for its spinal muscular atrophy drug
Swiss pharmaceuticals giant Novartis is buying US gene therapy pioneers AveXis for $8.7 billion, in a bid to boost its leadership in neuroscience treatment.
-
22 Mar
A mobile app experiment has suggested the next UK flu pandemic could kill 886,000 people
Scientists have predicted that the next flu pandemic to hit the UK could kill as many as 886,000 people and infect 43 million — about three-quarters of the entire population.
-
19 Mar
HSCT study suggests stem cell transplant ‘stunningly’ better than drugs at stopping MS relapses
A major study into haemotopoietic stem cell transplantation treatment for Multiple Sclerosis has found that it is “stunningly” better than drug treatments, according to one of the doctors involved.